top of page
external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus. 
Explore the latest updates from the life science industry.

Popular Content.

BIOTECH

NICE approves first licensed vitiligo treatment for NHS use in England

First licensed vitiligo therapy underscores opportunities for innovation, pipeline prioritisation, and market access in autoimmune skin disorders.

 Featured Articles. 

7-format11240.jpg
HEALTH

Sanome Expands NHS Rollout of AI Infection Detection Platform with Innovate UK £300k

7-format11240.jpg
HEALTH

Kaia Health Joins Sword Health to Scale AI-Driven Musculoskeletal Care

7-format11240.jpg
HEALTH

Killing Mosquitoes With the Smell of Flowers

7-format11240.jpg
BIOPROCESSING

FUJIFILM Biotechnologies Launches UK’s Largest Single-Use Biomanufacturing Facility

7-format11240.jpg
HEALTH

Sanome Partners With NHS Trusts to Deploy AI-Powered Clinical Intelligence for Earlier Infection Detection

7-format11240.jpg
HEALTH

A Simple Pad Could Transform Cervical Cancer Screening

7-format11240.jpg
BIOTECH

iXCells and Rosebud Team Up on Human Organoid Models

7-format11240.jpg
BIOTECH

First Human Egg 'Rejuvenation' Offers Hope for Older IVF Patients

7-format11240.jpg
PHARMA

Belite Bio Announces Landmark Phase 3 Success for Stargardt Disease

 Latest News. 

06th March, 2026

01.

Sanome Expands NHS Rollout of AI Infection Detection Platform with Innovate UK £300k.

Hospital partnerships and £300k Innovate UK SMART funding grant accelerate national deployment of MEMORI for earlier HAI detection

04th March, 2026

02.

Mursla Bio joins ABHI US Accelerator for EvoLiver rollout

Programme will support US market access and early clinical adoption of the company’s liver cancer surveillance blood test.

23rd February, 2026

03.

Broughton expands accredited cannabinoid testing

The introduction of ISO/IEC 17025-accredited methods for oils and tinctures reflects rising expectations for analytical robustness as cannabinoid formulations diversify and regulatory scrutiny intensifies.

16th February, 2026

04.

NICE approves first licensed vitiligo treatment for NHS use in England

First licensed vitiligo therapy underscores opportunities for innovation, pipeline prioritisation, and market access in autoimmune skin disorders.

Editor's Selects.

Weighing the Cost of Semaglutide

First Human Egg ‘Rejuvenation’ Offers Hope for Older IVF Patients

A Simple Pad Could Transform Cervical Cancer Screening

FUJIFILM Biotechnologies Launches UK’s Largest Single-Use Biomanufacturing Facility

Stay up-to-date. Connect with BioFocus on LinkedIn or subscribe to our mailing list.

bottom of page